Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9538

CNOC.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1500349 1.00
Hydrochloric Acid SCHEMBL428354 0.95
SCHEMBL22637 0.94
SCHEMBL8019633 0.89
SCHEMBL5800562 0.89
SCHEMBL7397825 0.89
Hydrochloric Acid SCHEMBL319290 0.87
SCHEMBL28613908 0.84
Hydrochloric Acid SCHEMBL1763117 0.84
Methylene Chloride SCHEMBL5560682 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 21852 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4205741-B1 CYP2E1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY-MEDIATED DISEASES SUZHOU LINGXI BIOTECHNOLOGY CO LTD (CN) 2025-12-10 EP claimed
US-20250361228-A1 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS CYCLERION THERAPEUTICS INC (US) 2025-11-27 US claimed
EP-4648766-A1 PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAME Relay Therapeutics, Inc. (US) 2025-11-19 EP claimed
EP-4570797-A2 NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS Cyclerion Therapeutics, Inc. (US) 2025-06-18 EP claimed
CN-119735550-A Synthesis method of fluorine-containing indazole derivative 三明学院 2025-04-01 CN claimed
WO-2024151930-A1 PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAME RELAY THERAPEUTICS, INC. (US) 2024-07-18 WO claimed
CN-117739256-B Corrosion-resistant and anti-aging gas bomb and manufacturing method and application thereof 沈阳欧施盾新材料科技有限公司 2024-07-12 CN claimed
US-12030874-B2 Processes and intermediates for the preparation of soluble guanylate cyclase stimulators CYCLERION THERAPEUTICS, INC. (US) 2024-07-09 US claimed
CN-118221665-A Methods and intermediates for preparing soluble guanylate cyclase stimulators 赛克里翁治疗有限公司 2024-06-21 CN claimed
CN-118184645-A Methods and intermediates for preparing soluble guanylate cyclase stimulators 赛克里翁治疗有限公司 2024-06-14 CN claimed
EP-0346655-B1 AN IMPROVED METHOD FOR PREPARING POLYMER SURFACES FOR SUBSEQUENT PLATING THEREON, AND IMPROVED METAL-PLATED PLASTIC ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 1993-08-18 EP claimed
EP-0498188-A2 Oximethers and fungicides containing them BASF Aktiengesellschaft (DE) 1992-08-12 EP claimed
EP-0438686-A2 Triazolylmethyl-cyclopropyl derivatives BAYER AG (DE) 1991-07-31 EP claimed
US-4983567-A Immunomodulators and methods of making same BIOMEASURE, INC. (US) 1991-01-08 US claimed
EP-0389244-A1 Process for synthesis of FK-506 C10-C18 intermediates MERCK & CO. INC. (US) 1990-09-26 EP claimed
US-4940797-A Process for synthesis of FK-506 C10-C18 intermediates MERCK & CO., INC. (US) 1990-07-10 US claimed
EP-0346655-A1 An improved method for preparing polymer surfaces for subsequent plating thereon, and improved metal-plated plastic articles made therefrom GENERAL ELECTRIC COMPANY (US) 1989-12-20 EP claimed
US-4873136-A MILD ETCHING; REMOVAL OF RESIDUAL FILM WITH CATIONIC SURFACTANT GENERAL ELECTRIC COMPANY (US) 1989-10-10 US claimed
US-4775449-A TREATING WITH NITROGEN OXYGEN COMPOUND IN WHICH NITROGEN IOS OVALENTY BONDED TO OXYGEN GENERAL ELECTRIC COMPANY (US) 1988-10-04 US claimed
EP-0283260-A1 Immunomodulators and method of making same BIOMEASURE, INC. (US) 1988-09-21 EP claimed